Our data suggests that post infection, CSE treatment may have resulted in either an expansion of IBV specific immune cells or the spleenocyte immune cells are producing more IFN-γ than none CSE treatment under the same IBV specific stimulation. The gene discussed is IFNG; the disease is infection.